Advertisement HSV Drug Development Services - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
More info about InPheno

HSV Drug Development Services


Building on the successful introduction of its new lines of product, InPheno now offers assays to identify and biologically profile the activity of compounds inhibiting Herpes simplex virus (HSV).

Replication of herpes simplex virus (HSV) in appropriate cell lines induces a marked cytopathy. This property is used in our assays (plaque or cytopathic effects inhibition) to evaluate and profile the activity of new antivirals against the propagation of HSV in cell culture. Our standard assays are performed using a HSV1 strain while HSV1 and 2 clinical isolates are available for compound profiling. At the present time we do not offer a cellular model of latency.
Quick Contact HSV Drug Development Services